Our results in HeFH indicate that high oxLDL and other components of dyslipidemia can contribute to low circulating SDF-1, which can, in turn, disrupt angiogenic and vascular repair functions in this patient population, contributing to their high cardiovascular risk. The gene discussed is CXCL12; the disease is metabolic syndrome.